| 2001 |
NUP160 and NUP133 are novel vertebrate nucleoporins that form a complex (the Nup160 complex) with Nup107, Nup96, and Sec13 in Xenopus egg extracts and assembled pores. They are accessible on the basket side of the nuclear pore and were identified through pulldown experiments using Nup98 and Nup153 fragments. Specific Nup160 and Nup133 fragments block poly[A]+ RNA export but not protein import or export, establishing a direct role for NUP160 in mRNA export. |
Pulldown from Xenopus egg extracts, immunofluorescence, co-immunoprecipitation, in vivo transport assays with transfected fragments |
The Journal of cell biology |
High |
11684705
|
| 2001 |
Human Nup107 and Nup133 form a nuclear pore subcomplex that also contains Nup96 and a novel nucleoporin designated hNup120 (later referred to as Nup160). This Nup107-160 subcomplex localizes stably to both faces of the NPC at interphase and redistributes to kinetochores during mitosis, revealing a connection between NPC scaffold components and kinetochore function. |
Two-hybrid screens, immunoprecipitation, immunofluorescence, photobleaching (FRAP) |
The Journal of cell biology |
High |
11564755
|
| 2004 |
The entire Nup107-160 complex, including NUP160 and three newly identified members (Nup37, Nup43, Seh1), is targeted as one entity to kinetochores from prophase to anaphase during mitosis. Depletion of individual members by RNAi phenocopies each other, indicating functional interdependence within the complex. |
GFP-tagging, immunofluorescence with specific antibodies, RNA interference knockdown, biochemical fractionation |
Molecular biology of the cell |
High |
15146057
|
| 2013 |
Electron tomography, single-particle EM, and crosslinking mass spectrometry show that 32 copies of the Nup107 subcomplex (which includes NUP160) assemble into two reticulated rings at the cytoplasmic and nuclear faces of the human NPC, defining how the scaffold accommodates large cargo transport. |
Electron tomography, single-particle electron microscopy, crosslinking mass spectrometry |
Cell |
High |
24315095
|
| 2014 |
BioID proximity-dependent biotinylation applied to constituents of the Nup107-160 complex (including NUP160) in living human cells defined the spatial organization of the NPC subcomplex and demonstrated a direct interaction of Nup43 with Nup85 within the extremely stable Nup107-160 structure, using NUP160-BioID fusions as a molecular ruler to define the labeling radius. |
Proximity-dependent biotin identification (BioID), mass spectrometry |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
24927568
|
| 2015 |
The NUP160-SLC43A3 fusion oncogene, arising from NUP160 truncation, is expressed in a subset of human angiosarcomas. Stable expression of the fusion in endothelial cells increases cell proliferation and induces an angiosarcoma-like gene expression pattern; subcutaneous implantation of fusion-expressing fibroblasts produces angiosarcoma-like tumors in vivo, implicating NUP160 truncation as oncogenic. |
Transcriptome sequencing, stable cell line expression, RNAi knockdown, xenograft tumor assay |
Cancer research |
Medium |
26527604
|
| 2015 |
Drosophila Nup160 (D. simulans allele) interacts genetically with Nup96 and additional autosomal factors to cause hybrid lethality in crosses with D. melanogaster; population genetic analysis reveals recurrent positive selection at Nup160 before and after speciation of the D. simulans clade, consistent with NUP160 evolving rapidly under natural selection at the species interface. |
Genetic crosses, introgression lines, population genetics analysis, complementation tests |
Genetics |
Medium |
26022241
|
| 2019 |
Compound-heterozygous mutations in NUP160 cause steroid-resistant nephrotic syndrome (SRNS). In a Drosophila nephrocyte model, silencing of Nup160 caused functional abnormalities, reduced cell size and nuclear volume, and disorganized nuclear membrane structure; these defects were rescued by wild-type human NUP160 but not by one of the disease-associated mutant alleles, establishing NUP160 mutations as causative for SRNS. |
Whole-exome/Sanger sequencing, Drosophila nephrocyte RNAi model, rescue experiments with wild-type and mutant human NUP160 |
Journal of the American Society of Nephrology : JASN |
High |
30910934
|
| 2018 |
Knockdown of NUP160 in mouse podocytes inhibits cell proliferation by decreasing cyclin D1 and CDK4 expression, increasing p27, and inducing S-phase arrest. It also promotes apoptosis, autophagy, and cell migration, and decreases expression and alters subcellular localization of slit-diaphragm proteins nephrin, podocin, and CD2AP while increasing α-actinin-4. |
shRNA knockdown in immortalized mouse podocytes, flow cytometry, Western blot, immunofluorescence |
Gene |
Medium |
29704630
|
| 2024 |
Podocyte-specific Nup160 knockout (Nup160podKO) mice generated by CRISPR/Cas9 and Cre/loxP develop progressive proteinuria and glomerulosclerosis, recapitulating the nephrotic syndrome phenotype of human NUP160 mutations and establishing NUP160 as causally required for podocyte integrity in a mammalian model. |
CRISPR/Cas9 and Cre/loxP conditional knockout mouse model, urine ACR measurement, serum albumin, histology |
Human molecular genetics |
High |
38224683
|
| 2025 |
Loss of Nup160 in podocyte-specific knockout mice decreases CDC42 protein levels and activity (despite elevated CDC42 mRNA), causing progressive proteinuria and foot-process fusion. This post-transcriptional dysregulation of CDC42 parallels findings from knockout of other outer-ring NPC components (NUP85, NUP107, NUP133), implicating CDC42 downregulation as a shared mechanism in NUP160-associated SRNS. |
CRISPR/Cas9 Cre/loxP knockout mouse with dual-fluorescent reporter, single-cell transcriptomics, proteomics of primary podocytes, CDC42 activity assay |
Human molecular genetics |
High |
40298220
|
| 2021 |
NUP160 knockdown in high-glucose-treated kidney tubular cells and STZ-induced diabetic nephropathy mice restores autophagic flux (increased LC3II/LC3I ratio, decreased p62) and inhibits NF-κB signaling, inflammation, and fibrosis, suggesting NUP160 negatively regulates autophagy in the diabetic kidney context. |
shRNA knockdown in NRK-52E cells, STZ mouse model, Western blot, immunofluorescence, histological staining |
Bioengineered |
Medium |
34533106
|
| 2019 |
MicroRNA-577 directly targets NUP160 mRNA (validated by dual-luciferase reporter assay); up-regulation of miR-577 reduces NUP160 expression in CML cells, inhibits cell proliferation and cycle progression, and enhances imatinib sensitivity, placing NUP160 downstream of miR-577 in CML drug resistance. |
qRT-PCR, dual-luciferase reporter assay, CCK-8 proliferation assay, flow cytometry, cell reverse experiment |
European review for medical and pharmacological sciences |
Medium |
31486501
|
| 2022 |
lncRNA HCG18 upregulates NUP160 by sponging miR-495-3p (a ceRNA mechanism); miR-495-3p directly targets NUP160 (confirmed by luciferase reporter). NUP160 overexpression reverses the protective effects of HCG18 knockdown in high-glucose-treated podocytes, placing NUP160 as a downstream effector in the HCG18/miR-495-3p axis regulating podocyte apoptosis and inflammation. |
Luciferase reporter assay, Western blot, RT-qPCR, flow cytometry, ELISA, in vivo STZ rat model |
Regenerative therapy |
Medium |
35785044
|